soul trial oral semaglutide cardiovascular outcomes results 2024 shows has positive CV benefits in type 2 diabetes Effects of oral semaglutide on

Most common incretin-based therapies and their mechanism of action, impact on glycemic control, weight, and specific evidence in MASLD Incretin-based therapies provide multiple metabolic benefits beyond weight loss, including improved -cell function, enhanced lipid metabolism, cardiovascular and renal protection, and anti-inflammatory effects [105,106]

While the weight loss was significant, Lilly did report a safety signal called dysesthesia in 8.8% and 20.9% of patients on the 9 mg and 12 mg doses, respectively

While results vary among individuals, such supplements can be considered one component of a broader skin health strategy

Inclusion criteria for all participants included the availability of CSF, PET, CT, or MRI data